NVAX250110P12500
- 0.00
- 0.000.00%
Novavax Newsroom
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies
Novavax, Inc. (NVAX) Is Attracting Investor Attention: Here Is What You Should Know
Strength Seen in Novavax (NVAX): Can Its 10.9% Jump Turn Into More Strength?
Nvidia, Palantir, Ionq, Novavax, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
Options Alert: Why Novavax (NVAX) Could Be the Biotech Hero of Trump 2.0
US Records First Human Bird Flu Death, High Levels Of Respiratory Illnesses: Vaccine Stocks Rally
Moderna, Novavax and Other Vaccine Names Extend Gains Amid COVID/flu Concerns
Moderna Stock Jumps Amid Bird Flu Vaccine Hope After First U.S. Death -- Barrons.com
Why Novavax (NVAX) Stock Is Rising
Shares of Vaccine Makers Are Trading Higher After the First Bird Flu Death Was Reporting in the US. Additionally, a Recent DCD Report Noted an Increase in Acute Respiratory Illness Activity.
Express News | US pharmaceutical stocks rose, with Moderna increasing by 7.5%, Novavax by 12.4%, Pfizer by 1.6%, and CureVac listed in the USA seeing a price increase of 10.6%.
Express News | Moderna up 7.5%, Novavax up 12.4%, Pfizer up 1.6%, U.S.-Listed Shares of CureVac up 10.6%
Express News | Shares of Vaccine Makers Rise in Early Trading
Possible Signal As Novavax Insiders Sell US$713k In Stock
'LDH Reports First U.S. H5N1-Related Human Death' - Louisiana Department Of Health
Vaccine Stocks Gain Amid Uptick in Flu, COVID-19, RSV
Novavax Inc. Stock Underperforms Tuesday When Compared To Competitors
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
Peering Into Novavax's Recent Short Interest
B.Riley Financial Maintains Novavax(NVAX.US) With Buy Rating, Maintains Target Price $22